Abernethy DR - Search Results

1

Tyrosine kinase-targeting drugs-associated heart failure.

Gronich N, Lavi I, Barnett-Griness O, Saliba W, Abernethy DR, Rennert G. Gronich N, et al. Among authors: abernethy dr. Br J Cancer. 2017 May 9;116(10):1366-1373. doi: 10.1038/bjc.2017.88. Epub 2017 Apr 11. Br J Cancer. 2017. PMID: 28399109 Free PMC article.

2

β2-adrenoceptor agonists and antagonists and risk of Parkinson's disease.

Gronich N, Abernethy DR, Auriel E, Lavi I, Rennert G, Saliba W. Gronich N, et al. Among authors: abernethy dr. Mov Disord. 2018 Sep;33(9):1465-1471. doi: 10.1002/mds.108. Mov Disord. 2018. PMID: 30311974

3

Hypothyroidism is a Risk Factor for New-Onset Diabetes: A Cohort Study.

Gronich N, Deftereos SN, Lavi I, Persidis AS, Abernethy DR, Rennert G. Gronich N, et al. Among authors: abernethy dr. Diabetes Care. 2015 Sep;38(9):1657-64. doi: 10.2337/dc14-2515. Epub 2015 Jun 12. Diabetes Care. 2015. PMID: 26070591

4

Linking MedDRA(®)-Coded Clinical Phenotypes to Biological Mechanisms by the Ontology of Adverse Events: A Pilot Study on Tyrosine Kinase Inhibitors.

Sarntivijai S, Zhang S, Jagannathan DG, Zaman S, Burkhart KK, Omenn GS, He Y, Athey BD, Abernethy DR. Sarntivijai S, et al. Among authors: abernethy dr. Drug Saf. 2016 Jul;39(7):697-707. doi: 10.1007/s40264-016-0414-0. Drug Saf. 2016. PMID: 27003817 Free PMC article.

5

HPLC-atmospheric pressure chemical ionization mass spectrometric method for enantioselective determination of R,S-propranolol and R,S-hyoscyamine in human plasma.

Siluk D, Mager DE, Gronich N, Abernethy D, Wainer IW. Siluk D, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Nov 15;859(2):213-21. doi: 10.1016/j.jchromb.2007.09.035. Epub 2007 Oct 7. J Chromatogr B Analyt Technol Biomed Life Sci. 2007. PMID: 17951120

6

Adverse Event Detection and Labeling in Pediatric Drug Development: Antiretroviral Drugs.

Momper JD, Chang Y, Jackson M, Schuette P, Seo S, Younis I, Abernethy DR, Yao L, Capparelli EV, Burckart GJ. Momper JD, et al. Among authors: abernethy dr. Ther Innov Regul Sci. 2015 Mar;49(2):302-309. doi: 10.1177/2168479014565471. Ther Innov Regul Sci. 2015. PMID: 30222418

7

Data Mining FAERS to Analyze Molecular Targets of Drugs Highly Associated with Stevens-Johnson Syndrome.

Burkhart KK, Abernethy D, Jackson D. Burkhart KK, et al. J Med Toxicol. 2015 Jun;11(2):265-73. doi: 10.1007/s13181-015-0472-1. J Med Toxicol. 2015. PMID: 25876064 Free PMC article.

8

Geriatric drug evaluation: where are we now and where should we be in the future?

Cho S, Lau SW, Tandon V, Kumi K, Pfuma E, Abernethy DR. Cho S, et al. Among authors: abernethy dr. Arch Intern Med. 2011 May 23;171(10):937-40. doi: 10.1001/archinternmed.2011.152. Arch Intern Med. 2011. PMID: 21606098 Review.

9

Drug Burden and its Association with Falls Among Older Adults in New Zealand: A National Population Cross-Sectional Study.

Jamieson HA, Nishtala PS, Scrase R, Deely JM, Abey-Nesbit R, Connolly MJ, Hilmer SN, Abernethy DR, Schluter PJ. Jamieson HA, et al. Among authors: abernethy dr. Drugs Aging. 2018 Jan;35(1):73-81. doi: 10.1007/s40266-017-0511-5. Drugs Aging. 2018. PMID: 29222667

10

Use of internet search logs to evaluate potential drug adverse events.

Sarntivijai S, Abernethy DR. Sarntivijai S, et al. Among authors: abernethy dr. Clin Pharmacol Ther. 2014 Aug;96(2):149-50. doi: 10.1038/clpt.2014.115. Clin Pharmacol Ther. 2014. PMID: 25056395

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

292 results

Search Page

Filters